Thoracic Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.6 | Q2 | 51.4% | 0.779 | Q2 | 76.4% |
| 2024 | 2.3 | Q2 | 53.7% | 0.795 | Q2 | 77.7% |
| 2023 | 2.3 | Q2 | 51.6% | 0.778 | Q2 | 78.9% |
| 2022 | 2.9 | Q3 | 53.8% | 0.730 | Q2 | 78.0% |
| 2021 | 3.2 | Q3 | 61.1% | 0.657 | Q2 | 75.7% |
| 2020 | — | — | 0.823 | Q2 | 80.5% | |
| 2019 | — | — | 0.688 | Q2 | 76.5% | |
| 2018 | — | — | 0.691 | Q2 | 74.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1759-7706
ISSN
1759-7714
country
UScoverage
2010-2026